友情提示:以下期刊信息可能会有更新,仅供参考,请在投稿前自行登录期刊官网仔细核实。
期刊名
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
CURR PHARM BIOTECHNO
ISSN / eISSN
1389-2010 / 1873-4316
目标和范围
Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include:
DNA/protein engineering and processing
Synthetic biotechnology
Omics (genomics, proteomics, metabolomics and systems biology)
Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes)
Drug delivery and targeting
Nanobiotechnology
Molecular pharmaceutics and molecular pharmacology
Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes)
Pharmacokinetics and pharmacodynamics
Applied Microbiology
Bioinformatics (computational biopharmaceutics and modeling)
Environmental biotechnology
Regenerative medicine (stem cells, tissue engineering and biomaterials)
Translational immunology (cell therapies, antibody engineering, xenotransplantation)
Industrial bioprocesses for drug production and development
Biosafety
Biotech ethics
Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.
Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.
DNA/protein engineering and processing
Synthetic biotechnology
Omics (genomics, proteomics, metabolomics and systems biology)
Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes)
Drug delivery and targeting
Nanobiotechnology
Molecular pharmaceutics and molecular pharmacology
Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes)
Pharmacokinetics and pharmacodynamics
Applied Microbiology
Bioinformatics (computational biopharmaceutics and modeling)
Environmental biotechnology
Regenerative medicine (stem cells, tissue engineering and biomaterials)
Translational immunology (cell therapies, antibody engineering, xenotransplantation)
Industrial bioprocesses for drug production and development
Biosafety
Biotech ethics
Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.
Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.
研究方向
生化与分子生物学
药学
CiteScore
5.60
查看趋势图
CiteScore 学科排名
类别 | 分区 | 排名 |
---|---|---|
Pharmacology, Toxicology and Pharmaceutics - Pharmaceutical Science | Q2 | #62/183 |
Pharmacology, Toxicology and Pharmaceutics - Biotechnology | Q2 | #128/311 |
Web of Science 核心收藏夹
Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
---|---|
Indexed | - |
类别 (Journal Citation Reports 2024) | 分区 |
---|---|
BIOCHEMISTRY & MOLECULAR BIOLOGY | Q4 |
PHARMACOLOGY & PHARMACY | Q3 |
H-index
73
出版国家或地区
UNITED STATES
出版商
Bentham Science Publishers B.V.
出版周期
Bimonthly
出版年份
2000
年文章数
139
Open Access
NO
通讯方式
BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR
认证评论
Revised: October 23, 2020
Accepted: October 23, 2020
The Impact Factor (IF) announced in 2021 has reached 2.837, showing a significant increase compared to the previous year. Students who have graduation requirements may consider submitting their work.
The overall charges collected are not low, and if the fast publication fee is not paid, the formal publication will be particularly slow.
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now